Adequate tissue for adequate diagnosis: what do we really need?

Guido M.J.M. Roemen, Axel zur Hausen, Ernst Jan M. Speel

Source: Eur Respir Monogr 2015; 68: 119-135
Journal Issue: Lung Cancer
Disease area: Thoracic oncology

Full text journal articleCongress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Guido M.J.M. Roemen, Axel zur Hausen, Ernst Jan M. Speel. Adequate tissue for adequate diagnosis: what do we really need?. Eur Respir Monogr 2015; 68: 119-135

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Peripheral lung lesions: what are the options for obtaining a tissue diagnosis?
Source: International Congress 2014 – PG10 Interventional pulmonology
Year: 2014

Diagnosis of osteoporosis in adult CF patients: the need for careful evaluation
Source: Eur Respir J 2001; 18: Suppl. 33, 539s
Year: 2001

Is information given to the patient prior to the bronchoscopic procedure adequate and understandable?
Source: Eur Respir J 2003; 22: Suppl. 45, 512s
Year: 2003

Increasing the need for upfront surgery: accurate physiological assessment
Source: Annual Congress 2010 - Selection criteria in lung cancer surgery: what really changed?
Year: 2010


Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Do we really need guidelines?
Source: Virtual Congress 2020 – Do we really need guidelines?
Year: 2020

Urgent need of a management plan for survivors of COVID-19
Source: Eur Respir J, 55 (4) 2000764; 10.1183/13993003.00764-2020
Year: 2020



Optimising COPD prevention: what do the doctors need?
Source: Annual Congress 2007 - Smoking and the lung
Year: 2007


In the era of personalised medicine, is pleural fluid cytology sufficient for oncological treatment?
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018

Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing?
Source: Eur Respir J 2014; 44: 1011-1022
Year: 2014



Are invasive physiological measures necessary for an optimal setting of pressure support in young patients with cystic fibrosis?
Source: Annual Congress 2003 - Physiology of NIV: understanding the effects and chosing the best settings
Year: 2003


Symptomatic, frail, elderly patients: the urgent need for comprehensive assessment and management
Source: Eur Respir J 2014; 44: 1397-1400
Year: 2014


Cleaning agents and asthma: what does the evidence currently tell us about diagnosis and management of these cases?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018


Maintaining currency and improving utility of COPD guidelines: an achievable goal?
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009

Cytology positive pleural aspirations: sufficient to guide treatment?
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019



Prognostic indices for COPD patient management: how many do we need?
Source: Eur Respir J 2011; 39: 223-224
Year: 2012


Protocols for the follow-up of pulmonary nodules: are they necessary?
Source: Annual Congress 2007 - Lung neoplasms
Year: 2007